ArticleFrontiers in immunology2025

Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1.

Shira Hagbi-Levi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.